Vaginal Hormone Therapy Is Not Linked to Breast Cancer Recurrence in Post-Menopausal PatientsAugust 29th 2022
An observational study found no association between single-agent vaginal estrogen therapy or menopausal hormone therapy and increased risk of recurrence or mortality in patients with breast cancer.
New Virtual Frailty Assessments Seek to Standardize Performance Measures for Older Adults With Blood CancerAugust 27th 2022
Investigators at Dana-Farber Cancer Institute are developing a virtual frailty assessment, which combines both patient-reported outcomes and standardized performance measures.
FDA Grants Ibrutinib Approval for Pediatric Graft-Versus-Host-DiseaseAugust 26th 2022
Ibrutinib is now an FDA-approved treatment for patients aged 1 year or older who have chronic graft-versus-host-disease. Prescription warnings include bleeding and cardiac problems, infections, high blood pressure, a decrease in blood cell count, and tumor lysis syndrome.
FDA Approves Single-Dose Betibeglogene Autotemcel for Patients With Beta-Thalassemia Who Require RBC TransfusionsAugust 18th 2022
Betibeglogene autotemcel is the first FDA-approved cell-based gene therapy to treat adult and pediatric patients with beta-thalassemia who need routine blood tranfusions.
Opinion: New Visitor Act in Florida Will Improve Quality of Life for Patients in Oncology UnitsAugust 3rd 2022
The Florida Senate recently passed the No Patient Left Alone Act SB 988, which will allow visitors back into the hospital, regardless of their COVID-19 vaccination, so that no patient will wake from surgery or find themselves in hospice, without a family member by their side.
Collaboration Between Pediatric Oncology Nurses and Social Workers Decreases Treatment-Related DistressJuly 20th 2022
Pediatric oncology nurses and social workers routinely collaborate not only in the biopsychosocial assessment of families’ psychosocial needs and distress, but in developing interventions that can improve a patient’s and family’s quality of life while in pediatric cancer treatment and in survivorship.
Are Oncology Nurses Underutilized in Positively Affecting the Opioid Epidemic?July 7th 2022
Gretchen McNally PhD, ANP-BC, AOCNP, discusses the potential impact advanced practice providers and nurses could have in the opioid pandemic if the correct educational opportunities were available.
Virtual Planning For Surgical Reconstruction May Improve Outcomes for Patients With Head and Neck CancerJune 29th 2022
Mandible reconstruction and maxilla reconstruction surgeries might be optimized with virtual surgical planning, according to an expert speaker at the 2022 Supportive Care in Cancer Annual Meeting.
Experts Make the Case for Buprenorphine Use in Cancer-Related Pain ManagementJune 28th 2022
Mary Lynn McPherson, PharmD, BCPS, FAAHPM, and Amy A. Case, MD, FAAHPM, argue that buprenorphine should play a larger role in cancer-related pain management because of its unique pharmacology and consequent safety profile.
Oral Minoxidil Demonstrates Efficacy in Treating Later Stage Alopecia in Cancer SurvivorsJune 27th 2022
Results of a single-center study presented at the 2022 ASCO Annual Meeting showed that oral minoxidil may be effective in treating late alopecia. Moving forward, these efforts in survivorship care will need to be expanded to less resourced areas, experts said.
ONS Annual Congress Focuses on Increasing Nurse Comfort and Patient Understanding in Cancer CareJune 24th 2022
This year’s congress showcased strategies for communicating sensitive topics, patient experiences with immunotherapy treatments, updates in the utility of medical cannabis, and more.